Antimicrobial resistance (AMR) is a global public health threat that urgently requires development of new treatment concepts. In general, these treatments should not only be able to overcome existing resistance, but designed to slow down or prevent emergence of new resistance mechanisms. Targeted protein degradation (TPD), whereby a drug redirects cellular proteolytic machinery towards degrading a specific target, is an emerging concept in drug discovery. Here, we demonstrate that a TPD strategy represents an effective approach for addressing AMR in Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB) and one of the deadliest bacterial pathogens. We developed proteolysis targeting chimeras active in bacteria (BacPROTACs) that bind to ClpC1, a component of the mycobacterial protein degradation machinery. The anti-Mtb BacPROTACs were derived from cyclomarins, natural products known to bind to ClpC1. To create dual targeting modalities, cyclomarins were dimerized by click chemistry or olefin metathesis, resulting in compounds that recruit and degrade ClpC1. The resulting BacPROTACs reduced levels of endogenous ClpC1 in a model organism Mycobacterium smegmatis (Msm), as well as displayed minimum inhibitory concentrations in the low micro- to nanomolar range in Msm and Mtb strains, including multiple drug resistant isolates. Additionally, the compounds also killed Mtb resident in macrophages. Taken together, anti-Mtb BacPROTACs that degrade ClpC1, a core component of the mycobacterial protein degradation machinery, represent a fundamentally different strategy for targeting Mtb and overcoming drug resistance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.